EFFECTS OF PROPIONIC-ACID AND PRAVASTATIN ON HMG-COA REDUCTASE-ACTIVITY IN RELATION TO FORESTOMACH LESIONS IN THE RAT

Citation
Je. Bueld et al., EFFECTS OF PROPIONIC-ACID AND PRAVASTATIN ON HMG-COA REDUCTASE-ACTIVITY IN RELATION TO FORESTOMACH LESIONS IN THE RAT, Pharmacology & toxicology, 78(4), 1996, pp. 229-234
Citations number
29
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
Journal title
ISSN journal
09019928
Volume
78
Issue
4
Year of publication
1996
Pages
229 - 234
Database
ISI
SICI code
0901-9928(1996)78:4<229:EOPAPO>2.0.ZU;2-C
Abstract
Administration of 4% propionic acid in powdered diet to rats for 12 we eks induces severe hyperplastic lesions in the forestomach mucosa. The mechanisms underlying this damage are not yet clear. Several lipophil ic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor s such as lovastatin and simvastatin produce forestomach lesions simil ar to propionic acid after oral administration and the degree of alter ations is correlated with their in vitro inhibitory potency (Kloss et al. 1998). Therefore it is possible, that sustained inhibition of HMG- CoA reductase and induction of hyperplasias may be somehow connected. For that reason we investigated, whether or not propionic acid has any influence on HMG-CoA reductase activity in vitro and in vivo, because propionic acid has been suggested to suppress liver cholesterol synth esis, and also whether or not pravastatin, a more polar HMG-CoA reduct ase inhibitor than lovastatin displays similar effects on forestomach mucosa. In untreated forestomach microsomes in vitro, propionic acid a t a concentration of 51 mM (pH 5.7) inhibited HMG-CoA reductase activi ty by 51+/-10%, but at pH 7.2 no inhibition of the enzyme could be det ected. Furthermore 4% propionic acid-treatment did not lower serum cho lesterol. In contrast to lovastatin (Kloss et al. 1991), oral administ ration of pravastatin (up to 25% in the diet) did not produce any fore stomach lesions in the rat. On the other hand, pretreatment with prava statin revealed that HMG-CoA reductase activity in microsomes exceeded the activity of control forestomach and liver microsomes by 4.9 fold and 6.7 fold respectively, whereas no induction of this enzyme (neithe r liver nor forestomach) could be observed by pretreatment with 4% pro pionic acid for 12 weeks. Despite increased hepatic HMG-CoA reductase activity, pravastatin-treatment significantly lowered serum cholestero l levels of rats. These results show that sustained inhibition of HMG- CoA reductase activity in forestomach microsomes is not strongly conne cted with hyperplasia development.